Evidence map›Paper›PMID 42845613›Full record

ArticlebioRxiv : the preprint server for biology2026

Reconsidering the Use of Dimethyl Sulfoxide for Xenobiotic-Gut Microbiota Interaction Studies.

Qiwen Cheng, Hannah Glesener, Aurely Sanchez Carreon, Lee E Voth-Gaeddert, Rosa Krajmalnik-Brown

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiwen ChengBiodesign Center for Health Through Microbiomes, Arizona State University, Tempe, AZ 85281, USA.ORCID 0000-0002-3673-5821
Hannah GlesenerBiodesign Center for Health Through Microbiomes, Arizona State University, Tempe, AZ 85281, USA.ORCID 0000-0001-5026-7625
Aurely Sanchez CarreonCollege of Liberal Arts and Sciences, Arizona State University, Tempe, AZ 85281, USA.ORCID 0009-0007-9041-8978
Lee E Voth-GaeddertBiodesign Center for Health Through Microbiomes, Arizona State University, Tempe, AZ 85281, USA.ORCID 0000-0002-9541-1958
Rosa Krajmalnik-BrownBiodesign Center for Health Through Microbiomes, Arizona State University, Tempe, AZ 85281, USA.ORCID 0000-0001-6064-3524

Funding

Aflatoxin Exposure, Growth Faltering, and the Gut Microbiome among Children in Rural GuatemalaR01ES033999 · NIEHS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Rosa Krajmalnik-Brown, Peter Rohloff · 2023 to 2026
$2.1M
NIEHS NIH HHS R01 ES033999
6 · The paper itself

Abstract

Introduction: Gut microbiota are vulnerable to foreign chemicals (xenobiotics) including pharmaceuticals, environmental pollutants, and dietary contaminants such as aflatoxin B1 (AFB1) and fumonisin B1 (FB1). Assessing the effect of these xenobiotics in the laboratory requires their dissolution in a solvent vehicle, such as dimethyl sulfoxide (DMSO). While DMSO is typically used at low concentrations under the assumption of neutrality, its independent impact on microbial dynamics is a potential experimental confounder that has not been fully explored. Methods: Human fecal microbiota were cultivated Results: DMSO significantly altered microbial metabolism and drove the consistent enrichment of Discussion: These findings demonstrate that DMSO can induce significant microbial shifts independent of the xenobiotics under study, potentially confounding biological interpretations. This highlights a critical need for rigorous vehicle validation and the identification of safe thresholds for solvents used in microbiota research.

Indexed as

aflatoxin B1Desulfovibrio desulfuricansdimethyl sulfoxidefumonisin B1Gut microbiota

Identifiers

PMID42845613
PMCPMC13640739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.